161 related articles for article (PubMed ID: 30681397)
1. Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe.
Wolfson LJ; Castillo ME; Giglio N; Meszner Z; Molnar Z; Vazquez M; Wysocki J; Altland A; Kuter BJ; Rickard J; Rampakakis E
Hum Vaccin Immunother; 2019; 15(4):932-941. PubMed ID: 30681397
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of varicella in children 1-12 years of age in Argentina, 2009-2014.
Giglio N; Monsanto H; Rampakakis E; Yang HK; Kuter BJ; Wolfson LJ
J Med Econ; 2018 Apr; 21(4):416-424. PubMed ID: 29357715
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015.
Meszner Z; Molnar Z; Rampakakis E; Yang HK; Kuter BJ; Wolfson LJ
BMC Infect Dis; 2017 Jul; 17(1):495. PubMed ID: 28705150
[TBL] [Abstract][Full Text] [Related]
4. Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.
Wysocki J; Malecka I; Stryczynska-Kazubska J; Rampakakis E; Kuter B; Wolfson LJ
BMC Public Health; 2018 Mar; 18(1):410. PubMed ID: 29587714
[TBL] [Abstract][Full Text] [Related]
5. The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe.
Wolfson LJ; Castillo ME; Giglio N; Mészner Z; Molnár Z; Vàzquez M; Wysocki J; Altland A; Kuter BJ; Stutz M; Rampakakis E; Roberts CS
BMC Public Health; 2019 Jun; 19(1):826. PubMed ID: 31242875
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of varicella in Europe in the absence of universal varicella vaccination.
Pawaskar M; Méroc E; Samant S; Flem E; Bencina G; Riera-Montes M; Heininger U
BMC Public Health; 2021 Dec; 21(1):2312. PubMed ID: 34930179
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.
Riera-Montes M; Bollaerts K; Heininger U; Hens N; Gabutti G; Gil A; Nozad B; Mirinaviciute G; Flem E; Souverain A; Verstraeten T; Hartwig S
BMC Infect Dis; 2017 May; 17(1):353. PubMed ID: 28521810
[TBL] [Abstract][Full Text] [Related]
8. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia.
Paternina-Caicedo A; De la Hoz-Restrepo F; Gamboa-Garay O; Castañeda-Orjuela C; Velandia-González M; Alvis-Guzmán N
Vaccine; 2013 Jan; 31(2):402-9. PubMed ID: 23174195
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource use and costs of varicella and its complications: A systematic literature review.
Williame I; George M; Shah HA; Homer N; Alderson D; Jamet N
Hum Vaccin Immunother; 2023 Dec; 19(3):2266225. PubMed ID: 37885425
[TBL] [Abstract][Full Text] [Related]
10. Use of health care resources for varicella in the paediatric population, Jordan.
Abdullat M; Hayajneh W; Banni Issa A; Alshurman A; Marar B; Al-Hajajrah A; Al-Razim A; Rickard J; Rampakakis E; Altland A; Wolfson LJ
East Mediterr Health J; 2021 Feb; 27(2):159-166. PubMed ID: 33665800
[TBL] [Abstract][Full Text] [Related]
11. Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review.
Arlant LHF; Garcia MCP; Avila Aguero ML; Cashat M; Parellada CI; Wolfson LJ
BMC Public Health; 2019 May; 19(1):528. PubMed ID: 31068173
[TBL] [Abstract][Full Text] [Related]
12. Burden of varicella in Central and Eastern Europe: findings from a systematic literature review.
Mészner Z; Wysocki J; Richter D; Zavadska D; Ivaskeviciene I; Usonis V; Pokorn M; Mangarov A; Jancoriene L; Man SC; Kristufkova Z; Jesenak M; Tešović G; Pluta J; Wolfson LJ
Expert Rev Vaccines; 2019 Mar; 18(3):281-293. PubMed ID: 30810402
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
14. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean--a systematic review and meta-analysis.
Bardach A; Cafferata ML; Klein K; Cormick G; Gibbons L; Ruvinsky S
Pediatr Infect Dis J; 2012 Dec; 31(12):1263-8. PubMed ID: 23188098
[TBL] [Abstract][Full Text] [Related]
15. Impact of varicella vaccination on health care utilization.
Zhou F; Harpaz R; Jumaan AO; Winston CA; Shefer A
JAMA; 2005 Aug; 294(7):797-802. PubMed ID: 16106004
[TBL] [Abstract][Full Text] [Related]
16. [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
Knuf M; Neiss A; Wutzler P
Klin Padiatr; 2006; 218(4):203-12. PubMed ID: 16819701
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
Wolfson LJ; Daniels VJ; Pillsbury M; Kurugöl Z; Yardimci C; Kyle J; Dinleyici EC
PLoS One; 2019; 14(8):e0220921. PubMed ID: 31408505
[TBL] [Abstract][Full Text] [Related]
18. Varicella vaccination in Japan, South Korea, and Europe.
Sadzot-Delvaux C; Rentier B; Wutzler P; Asano Y; Suga S; Yoshikawa T; Plotkin SA
J Infect Dis; 2008 Mar; 197 Suppl 2():S185-90. PubMed ID: 18419395
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
[TBL] [Abstract][Full Text] [Related]
20. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses.
Azzari C; Massai C; Poggiolesi C; Indolfi G; Spagnolo G; De Luca M; Gervaso P; de Martino M; Resti M
Curr Med Res Opin; 2007 Dec; 23(12):2945-54. PubMed ID: 17937842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
